Clinical Trial Update: Safety and Effectiveness Investigation for Dry, Non-Exudative Age Related Macular Degeneration (AMD) Using Rheopheresis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating rheopheresis for dry, non-exudative age-related macular degeneration has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Snippet

Sponsor: OccuLogix | Conditions: Age-Related Maculopathy | Phase 3 | Status: SUSPENDED